文献速递其他结缔组织病

IFN-α水平仅与抗MDA5阳性幼年皮肌炎患者肌肉疾病活动度相关

IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该前瞻性研究纳入两个独立队列共101例幼年皮肌炎(JDM)患者,采集400份样本,评估肌炎特异性抗体(MSAs)对I型干扰素(IFN-I)血浆水平与疾病活动度关联的影响。结果显示IFN-β在区分肌肉疾病活动度方面优于IFN-α且不受MSA表达影响,而IFN-α水平仅在MDA5阳性患者中与CMAS评分特异性相关。

要点

  • IFN-β在区分肌肉疾病活动与不活动、严重与非严重状态方面优于IFN-α。
  • IFN-β是肌肉疾病活动度的可靠生物标志物,不受MSA表达影响。
  • IFN-α水平与CMAS的关联仅见于抗MDA5阳性JDM患者。

核心结论

  • IFN-α水平与抗MDA5阳性患者肌肉临床评分的排他性关联提示亚组特异性病理生理机制。
  • IFN-I亚型(IFN-α与IFN-β)作为JDM肌肉疾病活动度循环生物标志物可能具有不同作用,取决于MSA表达。

研究设计与样本

  • 前瞻性研究,从两个独立队列纳入101例JDM患者,共获取400份样本。
  • 所有患者检测自身抗体水平,肌肉活动度采用儿童肌炎评估量表(CMAS)评估。
  • 采用两种特征明确的自制数字ELISA分别定量血浆中全部12种IFN-α亚型蛋白和IFN-β。
  • 采用ROC曲线分析确定与CMAS变化相关的IFN-I阈值。
  • 入组时采用Spearman检验评估IFN-I水平与CMAS相关性,纵向采用混合效应模型处理重复测量。

主要发现

  • MDA5阳性患者IFN-α水平较高,而IFN-β水平在各MSA亚组间相当。
  • IFN-β在区分活动性与非活动性肌肉疾病、以及严重与非严重疾病状态方面比IFN-α更有效。
  • 在整个疾病过程中,IFN-β被确定为肌肉疾病活动度的可靠生物标志物,不受MSA表达影响。
  • IFN-α水平仅在MDA5阳性患者中显示与CMAS的特异性关联。

关键数值与推荐

  • 肌肉活动度评估采用儿童肌炎评估量表(CMAS)。
  • 采用两种自制数字ELISA分别定量全部12种IFN-α亚型蛋白和IFN-β。
  • 采用ROC曲线分析确定与CMAS变化相关的IFN-I阈值。
  • 入组时采用Spearman检验、纵向采用混合效应模型评估IFN-I水平与CMAS相关性。

临床怎么用

  • IFN-β可作为JDM肌肉疾病活动度的循环生物标志物,不受MSA表达影响。
  • IFN-α水平与肌肉临床评分的关联仅见于抗MDA5阳性JDM患者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to establish the role of myositis-specific antibodies (MSAs) in the association between type I interferon (IFN-I) plasma levels and disease activity in juvenile dermatomyositis (JDM). METHODS: We prospectively obtained 400 samples from 101 JDM patients from two independent cohorts. Autoantibody levels were determined for all patients. Muscle activity was assessed using the Childhood-Myositis Assessment Scale (CMAS). Two characterized homebrew digital ELISAs measuring, respectively, all 12 IFN-α subtype protein and IFN-β were used to quantify IFN-I in patient plasma. Receiver operating characteristic (ROC) curve analysis was used to identify IFN-I thresholds associated with CMAS changes. Correlations between IFN-I levels and CMAS were assessed at recruitment using Spearman's test, and longitudinally using mixed-effects models to account for repeated measures. RESULTS: IFN-α levels were higher in melanoma differentiation-associated gene 5 (MDA5)-positive patients while IFN-β levels were comparable across MSA subgroups. IFN-β was found to be more effective than IFN-α in distinguishing between active and inactive muscle disease, and between severe and non-severe disease status. Over the disease course, we identified IFN-β as a reliable biomarker of muscle disease activity regardless of MSA expression. In contrast, IFN-α levels showed a specific association with CMAS only in MDA5-positive patients. CONCLUSION: The exclusive association of IFN-α levels with muscle clinical score in anti-MDA5-positive patients suggests a subgroup-specific pathophysiological mechanism. These findings underscore potentially distinct roles for IFN-I subtypes (IFN-α and IFN-β) as circulating biomarkers of muscle disease activity in JDM according to MSA expression.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Moreau TRJ, Bondet V, Veldkamp SR, et al. IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies. Rheumatology (Oxford). 2026. PMID: 41105236. doi:10.1093/rheumatology/keaf549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。